Emergent Biosolutions Inc (EBS)
Capital Expenditure
-$2.10M
Quarterly · Period ending: · USD
EBS Capital Expenditure
Latest reported-$2.10Mperiod ending
Latest reported-$2.10Mperiod ending
EBS Quarterly CapEx (-$8.90M → -$2.10M)
Quarterly CapEx
High-resolution chart · PNG
EBS capital expenditure history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -2,100,000 | |
| -2,400,000 | |
| -3,900,000 | |
| -3,400,000 | |
| -2,900,000 | |
| -3,600,000 | |
| -1,700,000 | |
| -5,800,000 | |
| -4,600,000 | |
| -10,800,000 | |
| -11,400,000 | |
| -12,600,000 | |
| -12,500,000 | |
| -15,100,000 | |
| -45,400,000 | |
| -27,900,000 | |
| -32,100,000 | |
| -32,200,000 | |
| -46,700,000 | |
| -55,200,000 | |
| -67,000,000 | |
| -56,100,000 | |
| -36,000,000 | |
| -45,700,000 | |
| -35,100,000 | |
| -24,200,000 | |
| -36,100,000 | |
| -15,300,000 | |
| -14,100,000 | |
| -21,400,000 | |
| -20,825,000 | |
| -26,058,000 | |
| -13,602,000 | |
| -11,615,000 | |
| -12,447,000 | |
| -12,776,000 | |
| -9,301,000 | |
| -20,304,000 | |
| -20,014,000 | |
| -16,997,000 | |
| -21,032,000 | |
| -18,214,000 | |
| -11,181,000 | |
| -13,950,000 | |
| -10,599,000 | |
| -9,082,000 | |
| -16,052,000 | |
| -5,221,000 | |
| -4,810,000 | |
| -4,590,000 | |
| -7,601,000 | |
| -20,297,000 | |
| -6,444,000 | |
| -7,679,000 | |
| -12,902,000 | |
| -10,022,000 | |
| -8,592,000 | |
| -22,329,000 | |
| -19,873,000 | |
| -17,358,000 | |
| -8,363,000 | |
| -8,432,000 | |
| -8,059,000 | |
| -5,411,000 | |
| -3,601,000 | |
| -5,030,000 | |
| -18,911,000 | |
| -5,282,000 | |
| -4,339,000 | |
| -4,755,000 | |
| -4,349,000 | |
| -3,921,000 | |
| -5,612,000 | |
| -6,931,000 | |
| -7,772,000 | |
| -8,854,000 | |
| -10,853,000 | |
| -16,490,000 | |
| -8,895,000 |